Takeda Advances New Type Of Diabetes Drug While Keeping Actos Alive
This article was originally published in PharmAsia News
Executive Summary
As Takeda Phrmaceutical works on new versions of its blockbuster drug facing patent expiration, it also is advancing development of a replacement treatment for diabetes